Investors

Financing History

Zymeworks received financing from Eli Lilly and Company, CTI Life Sciences Fund and private investors with the support of technology development grants from the Canadian National Research Council Industrial Research Assistance Program (NRC-IRAP).

Additional Information

Exisiting shareholders may obtain additional specific information about the Company by entering their username and password. If you are not a current investor and would like to learn more about Zymeworks, you may request access by contacting Dr. Ali Tehrani directly.

Login

Log in to password-protected area